Sensible was spun-out in early 2023 from Curative with the goal of bringing its 10 minute PCR platform (the Sensible Platform) to market. While at Curative, Sensible's team witnessed and participated in running over 2 million molecular point-of-care COVID-19 tests in the field. Building on this experience Sensible's team spent 2+ years developing and fine-tuning the Sensible platform, which is designed for speed and affordability without sacrificing accuracy or usability.
Sensible's goal is to make PCR point-of-care testing for infectious disease the standard of care. By reducing testing times and costs and improving usability, Sensible's platform makes this standard of care viable in a market full of products that don't.
Caution: This device is under development, It has not been approved for marketing in the US by the FDA.
Company Details
- Employees
- 4
- Address
- Los Angeles, Us
- Industry
- Medical Equipment Manufacturing
- NAICS
-
Medical Equipment and Supplies ManufacturingSurgical and Medical Instrument ManufacturingSurgical Appliance and Supplies ManufacturingDental Equipment and Supplies ManufacturingOphthalmic Goods ManufacturingDental Laboratories
- Website
- http://www.sensibledx.com
- HQ
- Los Angeles
Sensible Diagnostics, Inc. Questions
Sensible Diagnostics, Inc.'s website is http://www.sensibledx.com
Sensible Diagnostics, Inc.'s LinkedIn profile is https://www.linkedin.com/company/sensible-diagnostics-inc
Sensible Diagnostics, Inc. has
4 employees.
View email and phone details for 4
employees at Sensible Diagnostics, Inc..
Sensible Diagnostics, Inc.'s industry is
Medical Equipment Manufacturing
Sensible Diagnostics, Inc.'s top competitors are
Microgendx,
Beaubrain Healthcare,
Curative,
Autonomous Medical Devices Incorporated,
Access Genetics,
Shoreline Diagnostics,
Oraldna® Labs,
Dnaitech Ltd,
Sensible Biotechnologies,
Novus Diagnostics.
Sensible Diagnostics, Inc.'s categories are Medical Equipment Manufacturing
